ADAMTS2 and neoplasm: Six of the 10 (60%) proteins examined using TMA immunohistochemistry, HLAB, protein 14-3-3β, LTBP3, ADAMTS2, JAG2 and NME2, were significantly associated with clinical parameters which have shown to relate with tumor progression, invasion and metastasis.